Results 141 to 150 of about 8,194 (217)

Clinical and Genetic Evaluation of People with or at Risk of Hereditary ATTR Amyloidosis: An Expert Opinion and Consensus on Best Practice in Ireland and the UK. [PDF]

Adv Ther, 2022
Gillmore JD, Reilly MM, Coats CJ, Cooper R, Cox H, Coyne MRE, Green AJ, McGowan R, Moody WE, Hawkins PN.   +9 more
europepmc   +1 more source

Atypical Presentation of Hereditary ATTR Amyloidosis with Gastrointestinal and Hepatic Manifestations in an 88-Year-Old Woman: A Case Report. [PDF]

Am J Case Rep
Singh A, Panchal V, Gaddam SJ, Barzani Y, Fan X, Arora K, Mirza R, Lairmore T, Ramadas P.   +8 more
europepmc   +1 more source

Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness. [PDF]

Heart Fail Rev, 2022
Nativi-Nicolau JN, Karam C, Khella S, Maurer MS.   +3 more
europepmc   +1 more source

Cardiac involvement and clinical follow up of patients with hereditary transthyretin related amyloidosis associated with Glu89Gln mutation [PDF]

, 2015

core   +1 more source

Correction: Rationale and Design of ANTHOLOGY: An ATTR Amyloidosis Real-World Evidence Program Aiming to Address Gaps in Amyloidosis Care. [PDF]

Cardiol Ther
Gillmore JD, Hahn K, Smith JG, Conceição I, Tian Z, Grogan M, Pao C, Wittbrodt E, Järbrink K, Papas MA, Davis MK.   +10 more
europepmc   +1 more source

Phenotypic Differences of Glu89Gln Genotype in ATTR Amyloidosis From Endemic Loci: Update From THAOS. [PDF]

Cardiol Ther, 2021
Gentile L, Tournev I, Amass L, Chapman D, Mazzeo A, THAOS investigators.   +5 more
europepmc   +1 more source

Myocardium From Patients With ATTR Amyloidosis Produces Less Force Secondary to Increased Fibrosis. [PDF]

JACC Basic Transl Sci
Milburn GN, Bell J, Wellette-Hunsucker AG, Ruml H, Yackzan AT, Campbell KS.   +5 more
europepmc   +1 more source

An optimized imaging protocol for [^99mTc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis. [PDF]

J Nucl Cardiol, 2021
Schatka I, Bingel A, Schau F, Bluemel S, Messroghli DR, Frumkin D, Knebel F, Diekmann SM, Elsanhoury A, Tschöpe C, Hahn K, Amthauer H, Rogasch JMM, Wetz C.   +13 more
europepmc   +1 more source

ATTR Amyloidosis: development of cardiac symptoms during 6 years of follow up in different ATTR-variants [PDF]

, 2015

core   +1 more source

A Challenging Case of Wild-Type Transthyretin Amyloidosis (ATTR) Amyloidosis Treated With Cardiac Resynchronization Therapy. [PDF]

Cureus
Bansho H, Tomioka D, Geshi T, Sakai H, Nakagawa Y.   +4 more
europepmc   +1 more source